Dianthus Therapeutics (DNTH) PT Raised to $60 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Trevor Allred raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $60.00 (from $52.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
